blinatumomab

It is used for the treatment of adults, children, and young adults with acute lymphoblastic leukemia. It is used when the disease recurs (relapse), when it does not respond to previous treatments, or when small amounts of cancer cells are still present (minimal residual disease). It can also be used during consolidation therapy.

Form: powder and concentrate for solution for infusion

ATC: L01FX07

Manufacturer: AMGEN EUROPE B.V.